Quantcast

Latest Doxorubicin Stories

2011-04-02 00:00:28

MM-111 in pre-clinical combinations with lapatinib and endocrine therapies MM-302 in pre-clinical studies explaining its mechanism of action Cambridge, Mass. (Vocus/PRWEB) April 01, 2011 Merrimack Pharmaceuticals, Inc.

2011-03-21 01:30:00

SEATTLE, March 21, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that it has initiated its randomized pivotal trial of pixantrone for the treatment of relapsed/refractory diffuse large B-cell lymphoma ("DLBCL").

2011-03-16 08:32:00

MONTREAL, March 16 /PRNewswire/ - Soon, drug delivery that precisely targets cancerous cells without exposing the healthy surrounding tissue to the medication's toxic effects will no longer be an oncologist's dream but a medical reality, thanks to the work of Professor Sylvain Martel, Director of the Nanorobotics Laboratory at Polytechnique Montréal. Known for being the world's first researcher to have guided a magnetic sphere through a living artery, Professor Martel is...

2011-03-16 06:45:00

SYRACUSE, N.Y., March 16, 2011 /PRNewswire/ -- Scientists in Syracuse University's Chemistry Department have created a new drug delivery system expected to advance the effectiveness of cancer-killing drugs.

2011-03-10 00:30:00

SEATTLE, March 10, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced the final clinical trial design of a randomized pivotal trial of pixantrone for the treatment of diffuse large B-cell lymphoma ("DLBCL") following discussions with the U.S.

2011-03-09 18:24:10

Chemotherapy drug resistance contributes to treatment failure in more than 90 percent of metastatic cancers.

2011-03-03 00:30:00

SEATTLE, March 3, 2011 /PRNewswire/ -- Cell Therapeutics, Inc.

2011-03-02 06:12:00

BEVERLY, Mass., March 2, 2011 /PRNewswire/ -- Cellceutix Corporation (Pink Sheets: CTIX) today announced that it has received more data on Kevetrin(TM), the Company's flagship compound for the treatment of cancers.

2010-12-10 00:00:58

MM-111 first-in-human phase 1/ 2 and pharmacologic study in patients with advanced refractory HER2-Positive (HER2+) cancers.


Word of the Day
whirret
  • To give a box on the ear to.
The word 'whirret' may be onomatopoeic.